Dataset Information

Phosphorylated ?-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.

ABSTRACT: Parkinson's disease is the second most important neurodegenerative disorder worldwide. It is characterized by the presence of Lewy bodies, which are mainly composed of ?-synuclein and ubiquitin-bound proteins. Both the ubiquitin proteasome system (UPS) and autophagy-lysosomal pathway (ALS) are altered in Parkinson's disease, leading to aggregation of proteins, particularly ?-synuclein. Interestingly, it has been observed that copper promotes the protein aggregation process. Additionally, phosphorylation of ?-synuclein along with copper also affects the protein aggregation process. The interrelation among ?-synuclein phosphorylation and its capability to interact with copper, with the subsequent disruption of the protein degradation systems in the neurodegenerative process of Parkinson's disease, will be analyzed in detail in this review.

SUBMITTER: Castillo-Gonzalez JA

PROVIDER: S-EPMC5733240 | biostudies-other | 2017

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.

Castillo-Gonzalez Juan Antonio JA Loera-Arias Maria De Jesus MJ Saucedo-Cardenas Odila O Montes-de-Oca-Luna Roberto R Garcia-Garcia Aracely A Rodriguez-Rocha Humberto H

Parkinson's disease 20171123

Parkinson's disease is the second most important neurodegenerative disorder worldwide. It is characterized by the presence of Lewy bodies, which are mainly composed of α-synuclein and ubiquitin-bound proteins. Both the ubiquitin proteasome system (UPS) and autophagy-lysosomal pathway (ALS) are altered in Parkinson's disease, leading to aggregation of proteins, particularly α-synuclein. Interestingly, it has been observed that copper promotes the protein aggregation process. Additio ...[more]

PMID: 29333317

Similar Datasets

Project description:The loss of dopaminergic neurons of the nigrostriatal system underlies the onset of the typical motor symptoms of Parkinson's disease (PD). Lewy bodies (LB) and Lewy neurites (LN), proteinaceous inclusions mainly composed of insoluble ?-synuclein (?-syn) fibrils are key neuropathological hallmarks of the brain of affected patients. Compelling evidence supports that in the early prodromal phases of PD, synaptic terminal and axonal alterations initiate and drive a retrograde degeneration process culminating with the loss of nigral dopaminergic neurons. This notwithstanding, the molecular triggers remain to be fully elucidated. Although it has been shown that ?-syn fibrillary aggregation can induce early synaptic and axonal impairment and cause nigrostriatal degeneration, we still ignore how and why ?-syn fibrillation begins. Nuclear factor-?B (NF-?B) transcription factors, key regulators of inflammation and apoptosis, are involved in the brain programming of systemic aging as well as in the pathogenesis of several neurodegenerative diseases. The NF-?B family of factors consists of five different subunits (c-Rel, p65/RelA, p50, RelB, and p52), which combine to form transcriptionally active dimers. Different findings point out a role of RelA in PD. Interestingly, the nuclear content of RelA is abnormally increased in nigral dopamine (DA) neurons and glial cells of PD patients. Inhibition of RelA exert neuroprotection against (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) MPTP and 1-methyl-4-phenylpyridinium (MPP+) toxicity, suggesting that this factor decreases neuronal resilience. Conversely, the c-Rel subunit can exert neuroprotective actions. We recently described that mice deficient for c-Rel develop a PD-like motor and non-motor phenotype characterized by progressive brain ?-syn accumulation and early synaptic changes preceding the frank loss of nigrostriatal neurons. This evidence supports that dysregulations in this transcription factors may be involved in the onset of PD. This review highlights observations supporting a possible interplay between NF-?B dysregulation and ?-syn pathology in PD, with the aim to disclose novel potential mechanisms involved in the pathogenesis of this disorder.

Dataset Information

Phosphorylated ?-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.

Publications

Phosphorylated <i>α</i>-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure